US Patent 10562891 Quinazolinones as PARP14 inhibitors
Patent 10562891 was granted and assigned to Ribon Therapeutics on February, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10562891 Quinazolinones as PARP14 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.